Patents by Inventor Hawley K. Linke

Hawley K. Linke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230338404
    Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: June 30, 2023
    Publication date: October 26, 2023
    Applicant: ABBOTT LABORATORIES
    Inventors: JoMay Chow, Steven R. Davis, Rachael Buck, Geralyn O. Duska-McEwen, Hawley K. Linke
  • Patent number: 11690859
    Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: July 4, 2023
    Assignee: ABBOTT LABORATORIES
    Inventors: JoMay Chow, Steven R. Davis, Rachael Buck, Geralyn O. Duska-McEwen, Hawley K. Linke
  • Patent number: 11179406
    Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: November 23, 2021
    Assignee: ABBOTT LABORATORIES
    Inventors: JoMay Chow, Steven R. Davis, Rachael Buck, Geralyn O. Duska-McEwen, Hawley K. Linke
  • Publication number: 20200093846
    Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: November 27, 2019
    Publication date: March 26, 2020
    Applicant: ABBOTT LABORATORIES
    Inventors: JoMay Chow, Steven R. Davis, Rachael Buck, Geralyn O. Duska-McEwen, Hawley K. Linke
  • Publication number: 20200078385
    Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: November 11, 2019
    Publication date: March 12, 2020
    Applicant: ABBOTT LABORATORIES
    Inventors: JoMay Chow, Steven R. Davis, Rachael Buck, Geralyn O. Duska-McEwen, Hawley K. Linke
  • Patent number: 10471081
    Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
    Type: Grant
    Filed: January 9, 2017
    Date of Patent: November 12, 2019
    Assignee: ABBOTT LABORATORIES
    Inventors: JoMay Chow, Steven R. Davis, Rachael Buck, Geralyn O. Duska-McEwen, Hawley K. Linke
  • Publication number: 20170224714
    Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: January 9, 2017
    Publication date: August 10, 2017
    Applicant: ABBOTT LABORATORIES
    Inventors: JoMay Chow, Steven R. Davis, Rachael Buck, Geralyn O. Duska-McEwen, Hawley K. Linke
  • Patent number: 9539269
    Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
    Type: Grant
    Filed: December 22, 2011
    Date of Patent: January 10, 2017
    Assignee: Abbott Laboratories
    Inventors: JoMay Chow, Steven R. Davis, Rachael Buck, Geralyn O. Duska-McEwen, Hawley K. Linke
  • Publication number: 20120172319
    Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: December 22, 2011
    Publication date: July 5, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: JoMay Chow, Steven R. Davis, Rachael Buck, Geralyn O. Duska-McEwen, Hawley K. Linke
  • Publication number: 20030165606
    Abstract: It has been discovered that reducing the amount of lactose in standard non-soy protein based infant formulas will help to alleviate the regurgitation that is commonly experienced by infants during the first six to twelve months of life. Lactose levels should be 75 wt/wt %, or less, of the carbohydrate component.
    Type: Application
    Filed: July 11, 2002
    Publication date: September 4, 2003
    Inventors: John B. Lasekan, Julia A. Byard, Mary P. Franz, Hawley K. Linke